pFPP has been found in vitro to act mainly as a 5-HT1A receptor agonist, with some additional affinity for the 5-HT2A and 5-HT2C receptors.
It has also been shown to inhibit the reuptake of serotonin and norepinephrine, and to possibly induce their release.